Barcelona Alzheimer Treatment & Research Center

Artículo para la Categoría 2006

Propuesta para un registro clínico de demencias

Propuesta para un registro clínico de demencias. S. López-Pousa, J. Garre-Olmo, S. Montserrat-Vila, M. Boada-Rovira, L. Tárraga-Mestre, M. Aguilar-Barberá, R. Lozano.Fernández de Pinedo, J. Lorenzo-Ferrer. Neurología 2006; 43(1):32-38 PDF

Ecological assessment of executive functions in Mild Cognitive Impairment and mild Alzheimer’s Disease

Ecological assessment of executive functions in Mild Cognitive Impairment and mild Alzheimer’s Disease. Ana Espinosa, Montserrat Alegret, Mercè Boada, Georgina Vinyes, Sergi Valero, Pablo Martínez-Lage, Jordi Peña-Casanova, James T Becker, Barbara A. Wilson,  Lluís Tárraga.  Journal of the International Neuropsychological Society (JINS) 2009;15(5): 751–757 PDF

Relationship between the efficacy of rivastigmine and apolipoprotein E (e4) in patients with mild to moderately severe Alzheimer’s Disease

Relationship between the efficacy of rivastigmine and apolipoprotein E (e4) in patients with mild to moderately severe Alzheimer’s Disease. Blesa R, Aguilar M, Peña J, Boada M, Martínez S, Alom J, Hernández C, Sancho J, Fernández O, Gil E, Martí JF, Alzheimer Dis Assoc Disorder 2006; 20(4):

Validación española de la Behavioural Pathology in Alzheimer’s Disease Rating Scale (BEHAVE-AD)

Validación española de la Behavioural Pathology in Alzheimer’s Disease Rating Scale (BEHAVE-AD). Boada M, Tárraga L, Modinos G, Diego S, Reisberg B. Neurología 2006; 21(1):19-25.